About

Pascal Dugand, Technology Product Manager, Nemera, graduated as a polymer engineer from EAHP in Strasbourg, France. He holds a Masters in polymer mechanics and joined Plastic Omnium in 1990 where he started to work in development and innovation. In 2004, the medical division of Plastic Omnium was acquired by Rexam and more recently the four drug delivery devices plants, including the Innovation Centre, became Nemera.

Today, Mr Dugand is an experienced medical device developer engineer specialised in the development of parenteral delivery devices. He developed for Nemera own IP products including Safe’n’Sound and Safelia autoinjector as well as working on several customer injectable product development projects.

Contributions

PREFILLED SYRINGES

CONTROLLING AUTOINJECTOR NEEDLE INSERTION AND INJECTION SPEED

Pascal Dugand relates a study conducted by Nemera to determine a way to optimise the transition from needle insertion to syringe emptying for parenteral devices. This piece was originally presented as a poster at PDA Vienna 2017.

More contributions

PREFILLED SYRINGES

ADJUSTING & CONTROLLING INJECTION SPEED BY DESIGN: IMPACT ON PAIN PERCEPTION

Isabell Delcroix and Pascal Dugand describe a study of the multi-award-winning Safelia^® auto-injector platform, which showed how varying and slowing injection speed could reduce pain perception.

PREFILLED SYRINGES

A COLLABORATION THAT SAYS YOU’RE IN SAFE HANDS

William Dierick, Pascal Dugand and Adrien Tisserand describe a collaboration to create a compatibility between Terumo’s PLAJEX™; prefillable syringes with Nemera’s Safe‘n’Sound^® platform of add-on passive sharps injury protection devices for PFS.